We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01767311
Recruitment Status : Active, not recruiting
First Posted : January 14, 2013
Last Update Posted : June 15, 2022
Sponsor:
Collaborator:
Biogen
Information provided by (Responsible Party):
Eisai Inc.